Valuation Ipsen Deutsche Boerse AG

Stocks

Real-time Estimate Tradegate 02:36:37 24/08/2026 pm IST			5-day change	1st Jan Change
162.65 ^EUR	+0.09%		+1.50%	+36.73%

21/08	Ipsen S.A. completed the acquisition of Kartos Therapeutics, Inc.	CI
21/08	Ipsen Wraps Up Purchase of US-based Kartos Therapeutics	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	6,621	8,279	8,912	9,155	9,770	13,397	-	-
Change	-	25.05%	7.65%	2.72%	6.72%	37.13%	-	-
Enterprise Value (EV) ¹	6,758	7,894	8,860	9,020	9,225	12,159	11,098	10,288
Change	-	16.81%	12.22%	1.81%	2.28%	31.8%	-8.73%	-7.3%
P/E	10.4x	12.9x	14x	26.7x	22.4x	13.6x	13.9x	14x
PBR	2.42x	-	2.36x	2.22x	2.3x	2.62x	2.23x	1.92x
PEG	-	20.02x	-13.67x	-0.6x	0.8x	0x	-6.24x	-23.26x
Capitalization / Revenue	2.31x	2.74x	2.85x	2.69x	2.49x	2.95x	2.89x	2.77x
EV / Revenue	2.36x	2.61x	2.83x	2.65x	2.35x	2.68x	2.39x	2.13x
EV / EBITDA	5.8x	5.86x	10.1x	7.52x	6.67x	6.42x	6.25x	5.74x
EV / EBIT	6.68x	7.08x	8.85x	8.13x	7.13x	7.34x	7.36x	6.89x
EV / FCF	8.31x	9.02x	12.5x	11.6x	8.93x	9.43x	9.12x	8.37x
FCF Yield	12%	11.1%	8.02%	8.59%	11.2%	10.6%	11%	11.9%
Dividend per Share ²	1.2	1.2	1.2	1.4	1.4	1.535	1.532	1.655
Rate of return	1.49%	1.19%	1.11%	1.26%	1.18%	0.94%	0.94%	1.01%
EPS ²	7.76	7.81	7.73	4.15	5.32	12.02	11.75	11.68
Distribution rate	15.5%	15.4%	15.5%	33.7%	26.3%	12.8%	13%	14.2%
Net sales ¹	2,869	3,025	3,128	3,401	3,929	4,543	4,637	4,840
EBITDA ¹	1,166	1,348	881.4	1,200	1,383	1,893	1,776	1,792
EBIT ¹	1,011	1,115	1,001	1,109	1,294	1,656	1,508	1,494
Net income ¹	646.6	647.5	647.2	347.3	444.5	1,011	985.4	981.3
Net Debt ¹	137.8	-384.7	-52.9	-134.9	-544.5	-1,238	-2,299	-3,109
Reference price ²	80.50	100.50	107.90	110.70	119.00	163.40	163.40	163.40
Nbr of stocks (in thousands)	82,243	82,380	82,599	82,700	82,100	81,990	-	-
Announcement Date	11/02/22	09/02/23	08/02/24	13/02/25	12/02/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	35.74x	12.95x	26.26x	0.55%	1,11900Cr
JOHNSON & JOHNSON	30.06x	-	-	1.99%	65TCr
ABBVIE INC.	33.82x	7.82x	16.26x	2.59%	47TCr
ROCHE HOLDING AG	20.93x	4.96x	12.28x	2.66%	37TCr
NOVARTIS AG	22.59x	5.81x	14.4x	2.75%	30TCr
ASTRAZENECA PLC	21.46x	4.4x	12.56x	2%	26TCr
AMGEN INC.	27.79x	7.17x	12.73x	2.3%	24TCr
NOVO NORDISK A/S	13.71x	4.87x	10.23x	3.75%	21TCr
GILEAD SCIENCES, INC.	-44.65x	6.45x	25.18x	2.26%	18TCr
Average	17.94x	6.80x	16.24x	2.32%	42.22TCr
Weighted average by Cap.	25.52x	8.51x	18.71x	1.9%